Table of Contents

The increasing rates of obesity in the U.S. are fueling the popularity of weight loss injections like Wegovy and Saxenda. Both are glucagon-like peptide-1 (GLP-1) receptor agonists that reduce appetite and increase feelings of fullness, resulting in weight loss. Some people wonder, “Is Saxenda better than Wegovy — or is it the other way around?” If you’re on a journey to transform your body and become the healthiest version of yourself, this article on Wegovy vs. Saxenda explores the differences between these two widely used weight-loss medications, their side effects, and their cost.

Key Takeaways

  • Saxenda and Wegovy are GLP-1 drugs manufactured by Novo Nordisk and are FDA-approved to treat patients who are obese and overweight.
  • Wegovy contains semaglutide, which is administered once weekly, and Saxenda contains liraglutide, which is injected daily.
  • Wegovy has a half-life of approximately 7 days, whereas it takes Saxenda roughly 13 hours after injection to reduce its concentration by half.
  • The starting dose for Wegovy is 0.25 mg weekly, while Saxenda’s lowest dose is 0.6 mg daily.
  • Based on clinical trials, Wegovy is more effective for losing weight than Saxenda due to its more potent formula and longer half-life.

What Is the Difference Between Saxenda and Wegovy?

While both belong to the same class of drugs, Wegovy and Saxenda differ in many ways. Here’s a table summarizing their distinct features.

Feature Wegovy Saxenda
Active Ingredient Semaglutide Liraglutide
Drug Class GLP-1 receptor agonist GLP-1 receptor agonist
FDA Approval 2017 2010
Indicated Use Chronic weight management in adults and adolescents (12+) with obesity or overweight + comorbidity Chronic weight management in adults and adolescents (12+) with obesity or overweight + comorbidity
How It’s Taken Subcutaneous injection once weekly Subcutaneous injection once daily
Starting Dose 0.25 mg once weekly (titrated up) 0.6 mg once daily (titrated up)
Maximum Dose 2.4 mg once weekly 3.0 mg once daily
Storage Refrigerate between 2°C to 8°C (36°F to 46°F) before first use, then at room temperature from 8°C to 30°C (46°F to 86°F) for 28 days Prior to first use, refrigerate between 2°C to 8°C (36°F to 46°F), then from 15°C to 30°C (59°F to 86°F) after opening for 30 days
Common Side Effects Nausea, vomiting, diarrhea, constipation, abdominal pain, headache, fatigue Nausea, vomiting, diarrhea, constipation, abdominal pain, headache
Weight Loss Potential ~15% of body weight in trials in (STEP) ~5-10% of body weight in trials (SCALE)
Cost (without insurance) ~$1,350/month (varies) ~$1640/month (varies)
Half-life ~7 days ~13 hours

Active Ingredients, Drug Class, and FDA Approval

Hand holding a Saxenda pen with Saxenda box in background

Wegovy is FDA-approved for treating obesity in:

    • Adults with a body mass index (BMI) of 30 kg/m2 or greater (obesity)
    • Adults with a BMI of 27 kg/m2 or greater (overweight) with one weight-related comorbidity
    • Children aged 12 and older with obesity

Saxenda is also approved for treating obesity in:

    • Adults with a body mass index (BMI) of 30 kg/m2 or greater (obesity)
    • Adults with a BMI of 27 kg/m2 or greater (overweight) with one weight-related comorbidity
    • Children aged 12 and older who weigh more than 60 kg and have a BMI equivalent to 30 kg/m² in adults

Wegovy and Saxenda are both GLP-1 receptor agonists. They differ in their active ingredients and how they work in the body.

Wegovy contains semaglutide, while Saxenda contains liraglutide. These ingredients mimic the native GLP-1 to regulate appetite and blood sugar, aiding in weight loss.

Although both fall under the same drug class, semaglutide has a longer half-life of approximately 1 week, allowing for once-weekly dosing. Meanwhile, Saxenda requires daily injections because of its shorter half-life, which only lasts 13 hours.

Who makes Saxenda and Wegovy? Both GLP-1 drugs are manufactured by Novo Nordisk, the same pharmaceutical company that produces Ozempic.

Understanding the distinctions between the two helps patients and healthcare providers choose the best weight loss injection that suits their lifestyle and needs.

Mechanism of Action of Wegovy vs. Saxenda

Wegovy and Saxenda work by mimicking the GLP-1 hormone to control appetite, satiety, and blood sugar levels.

Semaglutide in Wegovy shares 94% of its structure with human GLP-1, allowing it to activate the GLP-1 receptor responsible for many metabolic processes.

In comparison, the liraglutide in Saxenda is 97% similar to the building blocks of native GLP-1, allowing it to activate specific receptors that control appetite. Natural GLP-1 has a half-life of only 1.5-2 minutes before it’s broken down by enzymes, which explains why its effects don’t last long. Liraglutide was designed to resist this breakdown, so GLP-1 can continue to regulate your appetite for up to 13 hours after injection.

By activating GLP-1 receptors, Wegovy and Saxenda help reduce cravings and improve glucose metabolism.

Wegovy vs. Saxenda Dose and Administration

3 wegovy pens A key difference between Wegovy and Saxenda is their initial dose, titration schedule, and frequency of administration.

Medication Starting Dose Titration Schedule Maintenance Dose Injection Frequency
Wegovy 0.25 mg once weekly Increase every 4 weeks: 0.25 mg ? 0.5 mg ? 1.0 mg ? 1.7 mg ? 2.4 mg 2.4 mg once weekly Weekly, at any time of day, with or without meals
Saxenda 0.6 mg once daily Increase weekly: 0.6 mg ? 1.2 mg ? 1.8 mg ? 2.4 mg ? 3.0 mg 3.0 mg once daily Daily, at any time of day, with or without meals

How often is Wegovy taken? Wegovy is administered once weekly via subcutaneous injection in the abdomen, thigh, or upper arm.. This once-weekly dosing schedule makes it more convenient for many users. On the other hand, Saxenda requires daily injections, which some may find challenging to fit into their schedule. Saxenda is injected daily into the same areas. Injection sites are rotated to minimize skin irritation due to daily injections.

Both injections start with lower doses slowly titrated to achieve optimal weight loss. The lowest dose of Saxenda is 0.6 mg per day, which increases weekly until the maintenance dose of 3.0 mg is reached. Wegovy starts at 0.25 mg weekly and goes up to 2.4 mg.

Wegovy vs. Saxenda Side Effects

Woman on couch experiencing nausea

Using these GLP-1 drugs to lose weight may result in adverse reactions, ranging from mild to severe.

Common Side Effects

Wegovy and Saxenda share many common side effects. At least 5% of users may experience the following:

    • Nausea
    • Diarrhea
    • Hypoglycemia
    • Dyspepsia
    • Fatigue
    • Constipation
    • Vomiting
    • Headache
    • Dizziness
    • Abdominal pain

These common side effects improve as the body adjusts to the medication’s effects.

Serious Side Effects

They also share severe health risks that include:

    • Acute pancreatitis
    • Thyroid C-cell tumors
    • Acute gallbladder disease
    • Hypoglycemia
    • Acute kidney injury
    • Hypersensitivity reactions
    • Heart rate increase
    • Suicidal behavior and ideation
    • Hypersensitivity reactions

Although rare, Wegovy users may develop pulmonary aspiration, while those who use Saxenda may experience diabetes-related vision loss.

Let your doctor know if you’re at risk for any of these conditions so they can determine if treatment is appropriate. If you’re concerned about the side effects of Saxenda vs.Wegovy, talk to your doctor before starting treatment to determine which option best suits your needs.

In general, Saxenda is considered to cause more tolerable adverse reactions than Wegovy. One reason is the slower and steadier titration of liraglutide, which makes gastrointestinal side effects like nausea and vomiting more manageable for many users.

Wegovy Tablets & Pen

Starting from $599

Ready to Buy Wegovy Online?

Choose BuyCanadianInsulin.com for affordable medications such as Wegovy tablets and pens and take control of your health with reliable, cost-effective options today!

SAVE 10% with coupon code:

SAVEWG10

Wegovy vs. Saxenda Cost Comparison

On average, Wegovy costs around $1,350 per month in local pharmacies in the U.S., while Saxenda costs $1,640 monthly. Pharmacy location, insurance coverage, and availability of savings programs can reduce monthly medication expenses.

Weight loss medications can be expensive, especially without insurance. Canadian online prescription platforms like Buy Canadian Insulin offer affordable weight loss medications for uninsured patients. Here’s how Saxenda and Wegovy prices compare between U.S. and Canadian pharmacies.

Medications Average Cost in the U.S. Buy Canadian Insulin
Wegovy Prefilled Pen Multi-Dose $1,350 $599
Saxenda Prefilled Pen $1,640 $515

Wegovy may be more cost-effective for some patients due to its once-weekly dose. However, others may prefer Saxenda’s daily dosing because of its more tolerable side effects.

Ultimately, the best weight loss injection depends on what’s accessible, affordable, and suitable for you. Always check with your provider or pharmacist to explore coverage and discount program options that can lower your medication costs.

Which Is More Effective for Weight Loss?

When comparing Wegovy vs. Saxenda for weight loss, the results often favor Wegovy because it leads to more significant weight reduction.

In clinical trials, participants took a once-weekly semaglutide injection at a dose of 2.4 mg for 68 weeks. At the end of the study, they lost an average of 15.3 kg (33.7 lbs), while those on the placebo lost 2.6 kg (5.7 lbs).

In another study, patients who were overweight and obese took 3.0 mg of liraglutide for 56 weeks. Participants in the treatment group lost an average of 8.4 kg (about 18.5 lbs), while those in the placebo group lost about 2.8 kg (around 6.2 lbs).

Based on these separate studies, Wegovy is more effective for weight loss than Saxenda. One reason is the potent formula and longer half-life of semaglutide. A single semaglutide dose can suppress appetite for up to seven days compared to the 13-hour effects of Saxenda.

Wegovy’s more prolonged action, potency, and higher dose make it more effective for weight loss.

Switching From Wegovy to Saxenda

Due to its more substantial weight loss effects, some people may consider switching from Saxenda to Wegovy. Others may go the other way — moving from Wegovy to Saxenda — because of side effect concerns or insurance limitations.

Always consult your doctor when changing medications so they can adjust your treatment plan accordingly. The two drugs have different dosing schedules and potencies, so you must work with your healthcare provider to determine your starting dose.

Alternative Weight Loss Medications

If Wegovy or Saxenda doesn’t suit you, your doctor may recommend alternative GLP-1 drugs to help you lose weight.

What medication is comparable to Saxenda? There’s no generic version of Saxenda, but Victoza, which also contains liraglutide, is another GLP-1 option. However, it’s approved for Type 2 diabetes. It may be a good option for patients who are obese or overweight with diabetes.

For Wegovy, doctors may consider several alternatives, including:

    • Zepbound: Contains tirzepatide and is approved for obesity and overweight
    • Mounjaro: Contains tirzepatide and is approved for Type 2 diabetes
    • Ozempic: Contains semaglutide but is approved for Type 2 diabetes

Always seek medical advice before switching therapies.

Saxenda or Wegovy: Which Should You Choose?

Saxenda and Wegovy are prescribed for managing obesity and weight-related conditions. Clinical trials have proven both are effective at reducing weight. However, Wegovy results in more significant weight loss because of its longer half-life and potent formula.

Meanwhile, Saxenda may be a better option for patients with high sensitivity to GLP-1’s side effects. Though less potent, its gradual titration may reduce side effects like nausea and vomiting.

Ultimately, the best weight loss injection depends on your health goals, tolerance to side effects, and budget. There’s no one-size-fits-all solution when it comes to losing weight. So, talk to your doctor to evaluate your health history, preferences, and goals to find the best treatment for you.

Frequently Asked Questions

Wegovy is generally more effective than Saxenda, with clinical trials demonstrating at least 15% weight loss in people treated with semaglutide. This greater weight reduction effect is due to its more potent active ingredient, semaglutide, and higher half-life.
Yes, you can switch from Saxenda to Wegovy for valid reasons, such as if you want to lose more weight. However, changes like this in the treatment plan should be done under your doctor’s supervision since doses and frequency differ.
Wegovy and Zepbound — which contain tirzepatide — are among the most potent and effective weight loss injections on the market. Both are FDA-approved for treating obesity and overweight.
Yes, you may try Wegovy if Saxenda didn’t yield the expected results. Medication effects vary from person to person. If Saxenda isn’t effective, you may talk to your doctor about switching to Wegovy or alternative GLP-1 drugs.
Wegovy and Saxenda are both GLP-1 agonists with similar action mechanisms. However, they contain different active base formulas —semaglutide for Wegovy and liraglutide for Saxenda. Therefore, they’re not the same medication.
No, Saxenda is not semaglutide. It contains liraglutide, a different GLP-1 receptor agonist that works the same way as semaglutide in regulating appetite and causing weight loss.

Original Publish Date: 5/12/2023 – Updated 6/03/2025